Literature DB >> 31385665

Nuclear ERK Translocation is Mediated by Protein Kinase CK2 and Accelerated by Autophosphorylation.

Alexander Plotnikov1, Dana Chuderland1, Yael Karamansha2,3, Oded Livnah2,3, Rony Seger4.   

Abstract

BACKGROUND/AIMS: The extracellular signal-regulated kinases (ERK) 1 and 2 (ERK1/2) are members of the mitogen-activated protein kinase (MAPK) family. Upon stimulation, these kinases translocate from the cytoplasm to the nucleus, where they induce physiological processes such as proliferation and differentiation. The mechanism of translocation of this kinase involves phosphorylation of two Ser residues within a nuclear translocation signal (NTS), which allows binding to importin7 and a subsequent penetration via nuclear pores. However, the regulation of this process and the protein kinases involved are not yet clear.
METHODS: To answer this point we developed specific anti phospho-SPS antibody, used this and other antibodies in Western blots and crystalized the phospho-mimetic mutated ERK.
RESULTS: Here we show that the phosphorylation of both Ser residues is mediated mainly by casein kinase 2 (CK2) and that active ERK may assist in the phosphorylation of the N-terminal Ser. We also demonstrate that the phosphorylation is dependent on the release of ERK from cytoplasmic anchoring proteins. Crystal structure of the phosphomimetic ERK revealed that the NTS phosphorylation creates an acidic patch in ERK. Our model is that in resting cells ERK is bound to cytoplasmic anchors, which prevent its NTS phosphorylation. Upon stimulation, phosphorylation of the ERK TEY domain releases ERK and allows phosphorylation of its NTS by CK2 and active ERK to generate a negatively charged patch in ERK, binding to importin 7 and nuclear translocation.
CONCLUSION: These results provide an important role of CK2 in regulating nuclear ERK activities. © Copyright by the Author(s). Published by Cell Physiol Biochem Press.

Entities:  

Keywords:  CK2; ERK; Importin7; MAPK; Nuclear Translocation

Mesh:

Substances:

Year:  2019        PMID: 31385665     DOI: 10.33594/000000144

Source DB:  PubMed          Journal:  Cell Physiol Biochem        ISSN: 1015-8987


  12 in total

1.  Enhanced MAPK1 Function Causes a Neurodevelopmental Disorder within the RASopathy Clinical Spectrum.

Authors:  Marialetizia Motta; Luca Pannone; Francesca Pantaleoni; Gianfranco Bocchinfuso; Francesca Clementina Radio; Serena Cecchetti; Andrea Ciolfi; Martina Di Rocco; Mariet W Elting; Eva H Brilstra; Stefania Boni; Laura Mazzanti; Federica Tamburrino; Larry Walsh; Katelyn Payne; Alberto Fernández-Jaén; Mythily Ganapathi; Wendy K Chung; Dorothy K Grange; Ashita Dave-Wala; Shalini C Reshmi; Dennis W Bartholomew; Danielle Mouhlas; Giovanna Carpentieri; Alessandro Bruselles; Simone Pizzi; Emanuele Bellacchio; Francesca Piceci-Sparascio; Christina Lißewski; Julia Brinkmann; Ronald R Waclaw; Quinten Waisfisz; Koen van Gassen; Ingrid M Wentzensen; Michelle M Morrow; Sara Álvarez; Mónica Martínez-García; Alessandro De Luca; Luigi Memo; Giuseppe Zampino; Cesare Rossi; Marco Seri; Bruce D Gelb; Martin Zenker; Bruno Dallapiccola; Lorenzo Stella; Carlos E Prada; Simone Martinelli; Elisabetta Flex; Marco Tartaglia
Journal:  Am J Hum Genet       Date:  2020-07-27       Impact factor: 11.025

2.  CFIm-mediated alternative polyadenylation remodels cellular signaling and miRNA biogenesis.

Authors:  Souvik Ghosh; Meric Ataman; Maciej Bak; Anastasiya Börsch; Alexander Schmidt; Katarzyna Buczak; Georges Martin; Beatrice Dimitriades; Christina J Herrmann; Alexander Kanitz; Mihaela Zavolan
Journal:  Nucleic Acids Res       Date:  2022-04-08       Impact factor: 16.971

Review 3.  CK2 and the Hallmarks of Cancer.

Authors:  May-Britt Firnau; Angela Brieger
Journal:  Biomedicines       Date:  2022-08-16

4.  Protective effect of Apremilast against LPS-induced acute lung injury via modulation of oxidative stress and inflammation.

Authors:  Naif O Al-Harbi; Faisal Imam; Mohammad Matar Al-Harbi; Khaldoon Aljeryan; Othman A Al-Shabanah; Khaled A Alhosaini; Lamya Saif Alqahtani; Muhammad Afzal; M D Khalid Anwer; Abdullah A Aldossari; Mohammed M Alanazi; Sary Alsanea; Mohammed A Assiri
Journal:  Saudi J Biol Sci       Date:  2022-02-23       Impact factor: 4.052

Review 5.  MAP/ERK Signaling in Developing Cognitive and Emotional Function and Its Effect on Pathological and Neurodegenerative Processes.

Authors:  Héctor Albert-Gascó; Francisco Ros-Bernal; Esther Castillo-Gómez; Francisco E Olucha-Bordonau
Journal:  Int J Mol Sci       Date:  2020-06-23       Impact factor: 5.923

6.  Phosphoproteomic Landscape of AML Cells Treated with the ATP-Competitive CK2 Inhibitor CX-4945.

Authors:  Mauro Rosales; Arielis Rodríguez-Ulloa; Vladimir Besada; Ailyn C Ramón; George V Pérez; Yassel Ramos; Osmany Guirola; Luis J González; Katharina Zettl; Jacek R Wiśniewski; Yasser Perera; Silvio E Perea
Journal:  Cells       Date:  2021-02-05       Impact factor: 6.600

7.  Dynamic Distribution of ASIC1a Channels and Other Proteins within Cells Detected through Fractionation.

Authors:  Libia Catalina Salinas Castellanos; Rodolfo Gabriel Gatto; Silvia Adriana Menchón; Matías Blaustein; Osvaldo Daniel Uchitel; Carina Weissmann
Journal:  Membranes (Basel)       Date:  2022-03-31

8.  Aberrant BMP2 Signaling in Patients Diagnosed with Osteoporosis.

Authors:  Hilary W Durbano; Daniel Halloran; John Nguyen; Victoria Stone; Sean McTague; Mark Eskander; Anja Nohe
Journal:  Int J Mol Sci       Date:  2020-09-21       Impact factor: 5.923

9.  Real-time sensing of MAPK signaling in medulloblastoma cells reveals cellular evasion mechanism counteracting dasatinib blockade of ERK activation during invasion.

Authors:  Marc Thomas Schönholzer; Jessica Migliavacca; Elena Alvarez; Karthiga Santhana Kumar; Anuja Neve; Alexandre Gries; Min Ma; Michael A Grotzer; Martin Baumgartner
Journal:  Neoplasia       Date:  2020-08-17       Impact factor: 5.715

Review 10.  Nuclear P38: Roles in Physiological and Pathological Processes and Regulation of Nuclear Translocation.

Authors:  Galia Maik-Rachline; Lucia Lifshits; Rony Seger
Journal:  Int J Mol Sci       Date:  2020-08-24       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.